Log In

Term Description

Qualitative detection of nucleic acids within the N gene of SARS coronavirus 2 (SARS-CoV-2) in various specimens, including lower & upper respiratory, serum, stool or urine, by nucleic acid amplification with probe-based detection using the N1 primer-probe set developed by the Centers for Disease Control and Prevention (CDC).[CDC: coronavirus/COVID-19/lab/]

Part Description

LP417599-0   SARS coronavirus 2 N gene
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC: coronavirus/2019-ncov]https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance Source: Regenstrief LOINC

Reference Information

TypeSourceReference
Package InsertCenters for Disease Control and PreventionThis document describes the use of real-time RT PCR (rRT-PCR) assays for the in vitro qualitative detection of 2019-Novel Coronavirus (2019-nCoV) in respiratory specimens and sera. The 2019-nCoV primer and probe sets are designed for the universal detection of SARS-like coronaviruses (N3 assay) and for specific detection of 2019-nCoV (N1 and N2 assays). Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus

LOINC Names Get Info

Fully-Specified Name
SARS coronavirus 2 N gene:PrThr:Pt:XXX:Ord:Probe.amp.tar.CDC primer-probe set N1
Long Common Name
SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
Short Name
SARS-CoV-2 N gene Spec Ql NAA N1
Display Name
SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 Ql (Specimen)
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19) N gene, Specimen

Part Model Get Info

  • Component
    SARS coronavirus 2 N gene
    LP417599-0
    • Analyte
      SARS coronavirus 2 N gene
      LP417599-0
      • Component Numerator
        SARS coronavirus 2 N gene
        LP417599-0
        • Component Numerator Core
          SARS coronavirus 2 N gene
          LP417599-0
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    PrThr
    LP217195-9
  • Time
    Pt
    LP6960-1
  • System
    XXX
    LP7735-6
    • System Core
      XXX
      LP7735-6
    • Super System
      NULL
       
  • Scale
    Ord
    LP7751-3
  • Method
    Probe.amp.tar.CDC primer-probe set N1
    LP417603-0

Ask at Order Entry

81959-9 Public health laboratory ask at order entry panel

This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.

LOINCNameR/O/CCardinalityExample UCUM Units
81959-9Public health laboratory ask at order entry panel
Indent81744-5Submitter's laboratory test method [Type] in Specimen
Indent81658-7Suspected organism [Identifier] in Specimen
Indent86952-9Preliminary testing done Specimen
Indent86953-7Preliminary testing result Specimen
Indent86955-2Preliminary testing affected submission for further testing Specimen
Indent95417-2Whether this is the patient's first test for condition of interest
Indent95418-0Whether patient is employed in a healthcare setting
Indent95419-8Whether the patient has symptoms related to condition of interest
Indent11368-8Illness or injury onset date and timeC
Indent77974-4Whether the patient was hospitalized for condition of interest
Indent95420-6Whether the patient was admitted to intensive care unit (ICU) for condition of interest
Indent95421-4Whether patient resides in a congregate care setting
Indent82810-3Pregnancy statusC
Indent30525-0Agea

Example Answer List: LL744-4

Source: Regenstrief Institute
AnswerCodeScoreAnswer ID
DetectedLA11882-0
Not detectedLA11883-8

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.68
Last Updated
Version 2.69 (MIN)
Order vs. Observation
Both

Member of these Panels

LOINCLong Common Name
94306-8SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection

Member of these Groups Get Info

LOINC GroupGroup Name
LG51017-8SARSCoV2 detection
LG51019-4SARSCoV2 molecular detection

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)SARS-CoV-2 (COVID-19) gen N:Přítomnost nebo práh:Časový bod:XXX:Ordinální:Amplifikace nukleových kyselin sadou Centers for Disease Control and Prevention primer-probe set N1
de-DEGerman (Germany)SARS-Coronavirus 2 N-Gen:Nachweis oder Schwellenwert:Zeitpunkt:XXX:Ordinal:Zielfragmentamplifikation mit Sondendetektion mit Primer-Sondenset N1 des Center for Disease Control and Prevention
el-GRGreek (Greece)Γονίδιο Ν κορωνοϊού SARS 2:PrThr:Pt:XXX:Ord:Δείκτης ενίσχυσης στόχου.εκκινητής CDC.σετ ανιχνευτή N1
Synonyms: CDC MICRO N Ord PrThr Pt XXX Ανιχνευτής Ανιχνευτής.ενίσχυση Ανιχνευτής.ενίσχυση.στόχου Γονίδιο Γονίδιο Ν κορωνοϊού SARS 2 Δείκτης ενίσχυσης στόχου.εκκινητής CDC.σετ ανιχνευτή N1 Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2
es-ESSpanish (Spain)Gen N de SARS-CoV-2 (COVID-19):PrThr:Punto temporal:XXX:Ord:Amplificación de ácido nucleico utilizando el conjunto de cebadores y sondas N1 de los Centros para el Control y la Prevención de Enfermedades
es-MXSpanish (Mexico)Gen del coronavirus 2 N del SARS:Presencia o umbral:Punto temporal:XXX:Ordinal:Amplificación de ácido nucleico utilizando el conjunto de cebadores y sondas de los Centros para el Control y la Prevención de Enfermedades N1
fr-FRFrench (France)Coronavirus SARS-CoV-2 gène N:Présence/Seuil:Ponctuel:Milieux divers:Qualitatif:PCR amplification de cible N1
it-ITItalian (Italy)SARS coronavirus 2, gene N:PrThr:Pt:XXX:Ord:Sonda.amp.tar.CDC set primer-sonda N1
Synonyms: Amplificazione degli acidi nucleici utilizzando il set primer-sonda N1 dei Centri per il controllo e la prevenzione della malattia Coronavirus della SARS Gene N di SARS-CoV-2 (COVID-19) Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
nl-NLDutch (Netherlands)SARS-CoV-2 N-gen:aanwezigheid:moment:XXX:ordinaal:probe-detectie met CDC primer-probe set N1
Synonyms: evere acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19 moleculaire techniek (PCR) met CDC-primer-probe set N1 probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PLPolish (Poland)Gen N SARS-CoV-2 (COVID-19):granica wykrywalności:punkt w czasie:XXX:uporządkowany:sonda.amp.cel.CDC Zestaw starter-sonda N1
Synonyms: amplifikacja kwasu nukleinowego przy użyciu zestawu starter-sonda N1 Amerykańskiego Centrum Kontroli i Zapobiegania Chorób (CDC) amplifikacja kwasu nukleinowego z detekcją za pomocą sondy amplifikacja z detekcją za pomocą sondy Koronawirus
zh-CNChinese (China)SARS 冠状病毒 2 N 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向.CDC 引物-探针组 N1
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ II N 型 SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 借助扩增的探针方法;借助扩增的探针法;探针法.扩增 借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 扩增型 扩增性 探针法.扩增.靶向.CDC（美国疾病控制与预防中心）引物-探针组（探针集合、探针集、探针组合） N1 时刻;随机;随意;瞬间 疾病预防控制中心;疾控中心;Centers for Disease Control and Prevention;美国疾病控制与预防中心;美国疾病控制和预防中心;美国疾病预防控制中心 经过扩增的 脱氧核糖核酸探针 遗传基因;遗传因子;吉恩;生物基因

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94307-6